Why did JPMorgan cut Albemarle's 2026–27 EBITDA and EPS estimates?

JPMorgan cut Albemarle's 2026 and 2027 adjusted EBITDA and EPS estimates due to continued weakness in lithium prices and delays in the Greenbushes CGP3 plant reaching full production.

What is JPMorgan's updated price target and rating for Albemarle stock?

JPMorgan lowered its price target for Albemarle to $140 for December 2027 from $160 and maintained a Neutral rating.

JPMorgan Cuts Albemarle 2026-27 EBITDA Estimates on Weak Lithium Prices

Aug 25, 2026

JPMorgan lowered its price target and earnings estimates for Albemarle to $140 by December 2027, citing weak lithium prices and production delays at the Greenbushes CGP3 plant.

scanx.trade

2026-04-08

Albemarle Corp. Stock Rises Wednesday, Still Underperforms Market

2026-04-09

UBS Group Issues Positive Forecast for Albemarle (NYSE:ALB) Stock Price

2026-04-13

Stanley Laman Group Ltd. Sells 7,590 Shares of Albemarle Corporation $ALB

2026-04-16

Greenwood Capital Associates LLC Sells 7,626 Shares of Albemarle Corporation $ALB

2026-04-18

Albemarle Corp. Hits Day High with 16.31% Surge in Stock Price